Gencurix Inc. (KOSDAQ:229000)
1,804.00
-11.00 (-0.61%)
Feb 18, 2025, 9:00 AM KST
Gencurix Company Description
Gencurix Inc. provides diagnostic solutions in South Korea.
Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection.
The company was founded in 2011 and is headquartered in Seoul, South Korea.
Gencurix Inc.
Country | South Korea |
Founded | 2011 |
Industry | Medical - Specialties |
Sector | Healthcare |
CEO | Sung-Rai Cho |
Contact Details
Address: Hanhwa Bizmetro Seoul, 152-733 South Korea | |
Phone | 82 2 2621 7038 |
Website | gencurix.com |
Stock Details
Ticker Symbol | 229000 |
Exchange | KOSDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | KRW |
ISIN Number | KR7229000005 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Sung-Rai Cho | Chief Executive Officer |